The protein assays market has seen considerable growth due to a variety of factors.
• In recent years, the protein assays market has seen quick expansion. The market, which stood at $2.9 billion in 2024, is estimated to rise to $3.29 billion in 2025, with an impressive 13.6% compound annual growth rate (CAGR). The prior period's growth is credited to advancements in areas such as proteomic research, drug discovery, development procedures, life sciences research, as well as boosted prevalence of chronic diseases and growing acceptance of personalized medicine.
The protein assays market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the protein assays market is anticipated to witness swift expansion, reaching a value of $5.74 billion by 2029 with a CAGR of 14.9%.
The surge during the projection period can be attributed to proliferating uses in clinical diagnostics, escalating focus on biomarker identification, augmented production and quality control in biopharmaceuticals, and innovative research methodologies incorporating technology. Key trends predicted for the forecast span include a rise in the application of proteomics in drug discovery, the evolution of highly sensitive assay kits, a concentration on standardization and test reproducibility, assimilation of proteomic data with various other omics data, and broadening of protein assays' role in clinical diagnostics.
The protein assay market's progression is expected to be propelled by the expansion in the pharmaceutical sector. The pharmaceutical industry is notable for its concentration on research, development, production, and distribution of therapeutic drugs and medications aimed at disease prevention, diagnosis, and treatment. The sector's growth can be attributed to several factors, including an increased global health demand, enhanced healthcare investment, and the need for preventive care. Protein assays play a pivotal role in this industry as they facilitate the precise estimation of protein concentration and activity - elements crucial to drug discovery, development, and quality assurance. For example, the Government of Canada reported in August 2024 that in 2022, domestic pharmaceutical trade exports escalated to 12.79 from 10.71 in 2021, alongside an increase in imports to 30.21 from 26.63 in 2021. This indicates a growth in both export and import activities, demonstrating a burgeoning pharmaceutical trade sector. Hence, the pharmaceutical industry's expansion is fostering the growth of the protein assay market.
The protein assays market covered in this report is segmented –
1) By Product Type: Reagents And Kits, Instruments
2) By Technology Type: Absorbance Based Protein Assays, Colorimetric Protein Assays, Fluorescence Based Protein Assays
3) By End User: Pharmaceutical Industry, Biotechnology Industry, Clinical Laboratories, Hospitals, Academic Research Institutes
Subsegments:
1) By Reagents And Kits: Colorimetric Assay Kits, Fluorescent Assay Kits, Luminescent Assay Kits, Other Assay Kits
2) By Instruments: Spectrophotometers, Microplate Readers, Other Analytical Instruments
Key players in the protein assay market are prioritizing the development of novel solutions, including 3D spatial analysis kits. These kits contain a variety of tools, software, or resources, which help analyze and represent spatial data in three dimensions. An example of this came in June 2023 when Sweden's Pixelgen Technologies AB introduced the ‘Pixelgen Single Cell Spatial Proteomics Kit’. This kit, built upon MPX technology, can potentially elevate the understanding of cellular activities, thereby contributing to the progress made in basic scientific knowledge, speeding up drug discovery and development, and enhancing diagnostic abilities. The first version of the Pixelgen SCSP Kit will feature 76 protein assays and 4 control measures for combined testing.
Major companies operating in the protein assays market include:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• Roche Diagnostics International AG
• Danaher Corporation
• Merck KGaA
• Siemens Healthineers AG
• R&D Systems Inc.
• Lonza Group AG
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Takara Bio Inc.
• Qiagen N.V.
• Promega Corporation
• Abcam plc
• Cell Signaling Technology Inc.
• BioVision Inc.
• Cayman Chemical Company
• Enzo Life Sciences Inc.
• Novus Biologicals LLC
• Abnova Corporation
• Elabscience Biotechnology Co Ltd.
• Geno Technology Inc.
• Cytoskeleton Inc.
North America was the largest region in the protein assays market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global protein assays market report during the forecast period. The regions covered in the protein assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.